Veradigm Inc.
MDRX · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 144.03 | 79.24 | -445.35 |
| FCF Yield | 0.00% | 0.00% | -0.00% | 0.00% |
| EV / EBITDA | 0.00 | 49,254.07 | 155,001.71 | 153,528.26 |
| Quality | ||||
| ROIC | 0.00% | 0.76% | 0.22% | 0.37% |
| Gross Margin | 0.00% | 54.92% | 52.67% | 51.50% |
| Cash Conversion Ratio | – | 2.58 | 1.45 | 3.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -20.65% | -15.02% | -10.07% | -5.33% |
| Free Cash Flow Growth | -100.00% | 272.41% | -119.56% | 27.29% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -6.87 | -25.64 | 15.51 |
| Interest Coverage | 0.00 | 20.07 | -2.84 | 3.08 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 122.34 | 105.99 | 122.13 |